Cattaneo, D., Riva, A., Columpsi, P., Lapadula, G., Filice, C., Gervasoni, C. (2020). Dosing of Dolutegravir in TB/HIV Coinfected Patients on Rifampicin: Twice Is (Always) Better Than Once. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 84(3), E17-E20 [10.1097/QAI.0000000000002352].

Dosing of Dolutegravir in TB/HIV Coinfected Patients on Rifampicin: Twice Is (Always) Better Than Once

Lapadula, G;
2020

Lettera in rivista
dolutegravir, tuberculosis
English
2020
84
3
E17
E20
none
Cattaneo, D., Riva, A., Columpsi, P., Lapadula, G., Filice, C., Gervasoni, C. (2020). Dosing of Dolutegravir in TB/HIV Coinfected Patients on Rifampicin: Twice Is (Always) Better Than Once. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 84(3), E17-E20 [10.1097/QAI.0000000000002352].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/326202
Citazioni
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
Social impact